|
DURHAM, N.C., Nov. 15 /PRNewswire/ -- AlphaMed Press, publisher of the
journal Stem Cells(R), has named Donald G. Phinney and Miodrag Stojkovic as
co-editors.
Curt I. Civin, current STEM CELLS Editor, retires after eight years of
unprecedented growth in areas of the journal's most significant metrics:
Impact Factor, number of pages published, and number of manuscripts
submitted. During his tenure as editor-in-chief, Dr. Civin was assisted by
three outgoing senior editors: Alan M. Gewirtz, Robert G. Hawley, and
Margaret A. Goodell.
Martin J. Murphy, STEM CELLS' Executive Editor, expressed his
appreciation to the retiring editors. "I am deeply appreciative for the
cumulative 26 years of leadership that Drs. Civin, Gewirtz, Hawley and
Goodell have unstintingly devoted to STEM CELLS," he said. "We are honored
by the care that they devoted to the review process, a process that has
been enhanced by an order of magnitude under their inspiring leadership."
In the last six years, STEM CELLS' Impact Factor has risen from 2.689
to 7.924, and the number of pages published has doubled in the last two
years alone, as has the number of manuscripts submitted.
The new editors, Phinney and Stojkovic, are not new to STEM CELLS. For
the past year they have served as Associate Editors with responsibility to
oversee the peer review of all manuscripts. They will be supported by a
team of new associate editors.
Donald G. Phinney, PhD, is Professor of Immunology and Microbiology and
Associate Director for Research at Tulane's Center for Gene Therapy.
Professor Phinney investigates the basic biology of Mesenchymal Stem Cells
and their potential use for treatment of chronic lung disease and disorders
of the central nervous system. Studies in mice have spurred pre-clinical
trials to evaluate the safety and efficacy of intracranial stem cell
transplantation for the treatment of neurological sequelae resulting from
lysosomal storage diseases.
Miodrag Stojkovic, PhD, is Deputy Director of Centro de Investigacion
Principe Felipe and head of its Cellular Reprogramming Laboratory,
Valencia, Spain. In September 2006, a team led by Professor Stojkovic
announced derivation of Pluripotent Human Embryonic Stem Cells (hESC) from
non-viable early human embryos that had stopped their cleavage. Using
surplus and donated embryos, the scientists demonstrated that these
arrested embryos could be used under suitable laboratory conditions for
derivation of hESC. Published in STEM CELLS, the technique may help to
understand and fight debilitating diseases.
About STEM CELLS(R)
STEM CELLS(R), the international journal of cell Differentiation and
Proliferation, publishes original articles at the leading edge of stem cell
research and Regenerative Medicine. Beginning its 26th year of publication
in 2008, STEM CELLS(R) is the first journal devoted to this fast-paced
field of research. Its Impact Factor, the highest of all journals devoted
to the peer reviewed publication of stem cells literature, is 7.924. For
more information, please visit http://www.StemCells.com or contact:
George Kendall
Director of Operations and Business Development
AlphaMed Press
318 Blackwell Street, Suite 260
Durham, NC 27701
E-mail:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
|
NEWS & PRESS 
